View
comments
After the success of The Queen’s Gambit, there were no doubt high hopes for The Year of Women in Chess in 2022.
But the International Chess Federation (FIDE) has instead found itself under fire from fans and female players after announcing a deal with a breast enlargement company to promote the game.
Its decision to partner with Establishment Labs, a company that produces and markets implants under the Motiva brand, prompted one anonymous player to write on the popular chess site Lichess: ‘Shouldn’t chess – a game reliant on brains rather than breasts – be distancing itself from that kind of reductive and misogynistic line of thinking?’
Sales of sets soared after the success of The Queen’s Gambit, the multi-award-winning Netflix drama which charted the rise of orphan prodigy Beth Harmon, played by Anya Taylor-Joy
Chess has only 39 female grandmasters out of a total of 1,300 and has strained to promote the game among women.
Sales of sets soared after the success of The Queen’s Gambit, the multi-award-winning Netflix drama which charted the rise of orphan prodigy Beth Harmon, played by Anya Taylor-Joy.
But many believe the new sponsorship deal, set to run throughout next year,
